Jill M. Wagner - Concepedia

Author

Jill M. Wagner

Mayo Clinic

Also Known As

Dohn G. Glitz, J. M. Wagner, J. Wagner, J.M. Wagner, Jill M Wagner, Jill M. Wagner, Jill M Wagner

Publications

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic University of Washington University of California, Los Angeles Aarhus University WinnMed

About

Jill M. Wagner is an author at Mayo Clinic specializing in medicine, pathology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	265
2	Public Health	2	2	73
3	Engineering	1	1	15
4	Natural Sciences	1	1	92
5	Biostatistics	1	1	15

Jill M. Wagner

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
The Rad9–Hus1–Rad1 (9–1–1) clamp activates checkpoint signaling via TopBP1 Sinny Delacroix, Jill M. Wagner, Masahiko Kobayashi, Genes & Development	2007	457
Eosinophil infiltration and degranulation in normal human tissue Masahiko Katô, Gail M. Kephart, Nicholas J. Talley, The Anatomical Record	1998	209
Gemcitabine-Induced Activation of Checkpoint Signaling Pathways That Affect Tumor Cell Survival Larry M. Karnitz, Karen S. Flatten, Jill M. Wagner, Molecular Pharmacology	2005	136
Cisplatin-Induced DNA Damage Activates Replication Checkpoint Signaling Components that Differentially Affect Tumor Cell Survival Jill M. Wagner, Larry M. Karnitz Molecular Pharmacology	2009	134
Pharmacological Abrogation of S-Phase Checkpoint Enhances the Anti-Tumor Activity of Gemcitabine In Vivo David J. Matthews, Michael Yakes, Jason Chen, Cell Cycle	2007	133
Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes Sanjiv Sur, Dohn G. Glitz, Hirohito Kita, Journal of Leukocyte Biology	1998	132
Chaperoning Checkpoint Kinase 1 (Chk1), an Hsp90 Client, with Purified Chaperones Sonnet J.H. Arlander, Sara J. Felts, Jill M. Wagner, Journal of Biological Chemistry Purified ChaperonesSignal TransductionSignaling PathwayCell RegulationCheckpoint Kinase 1	2005	92
A Novel and Highly Divergent Homolog of Human Eosinophil Granule Major Basic Protein Douglas A. Plager, David A. Loegering, Deborah A. Weiler, Journal of Biological Chemistry	1999	74
53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer Rachel M. Hurley, Andrea E. Wahner Hendrickson, Daniel W. Visscher, Gynecologic Oncology MedicinePathologyPotential PredictorTumor SuppressorCancer Genetics	2019	74
Identification of Angiotensinogen and Complement C3dg as Novel Proteins Binding the Proform of Eosinophil Major Basic Protein in Human Pregnancy Serum and Plasma Claus Oxvig, Jesper Haaning, Lene Juel Kristensen, Journal of Biological Chemistry	1995	71

Page 1